93 related articles for article (PubMed ID: 16646289)
1. [Practical application of proliferation markers' (MIB-1, PCNA, AgNOR) expression analysis for differential diagnostics of nodular thyroid lesions].
Lewy-Trenda I; Janczukowicz J; Wierzchniewska-Lawska A
Wiad Lek; 2006; 59(1-2):32-7. PubMed ID: 16646289
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of MIB-1 immunoreactivity and nucleolar organizer regions in nonneoplastic and neoplastic thyroid lesions.
Lewy-Trenda I; Bieńkiewicz M
Pol J Pathol; 1999; 50(3):129-38. PubMed ID: 10624114
[TBL] [Abstract][Full Text] [Related]
3. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma.
Wang SL; Li SH; Chen WT; Chai CY
APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical study in differential diagnosis of benign and malignant lesions of the thyroid gland].
Kazantseva IA; Fedosenko AK; Gurevich LE
Arkh Patol; 2001; 63(4):18-21. PubMed ID: 11534185
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
[TBL] [Abstract][Full Text] [Related]
6. Morphometric studies on fine-needle aspirates from follicular proliferative lesions of the thyroid.
Cavallari V; Maiorana A; La Rosa GL; Maiorana MC; Scimone S; Fano RA
Pathologica; 1989; 81(1074):441-6. PubMed ID: 2626280
[TBL] [Abstract][Full Text] [Related]
7. Morphometry in the cytologic evaluation of thyroid follicular lesions.
Nagashima T; Suzuki M; Oshida M; Hashimoto H; Yagata H; Shishikura T; Koda K; Nakajima N
Cancer; 1998 Apr; 84(2):115-8. PubMed ID: 9570215
[TBL] [Abstract][Full Text] [Related]
8. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic contribution of HBME-1 and anti-cytokeratin-19 antibodies in thyroid pathology: a retrospective study of 163 cases].
Ziadi S; Trimeche M; Zermani R; Elmay A; Baltagi-Ben Jilani S
Tunis Med; 2005 May; 83(5):274-8. PubMed ID: 16044900
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
[TBL] [Abstract][Full Text] [Related]
12. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
[TBL] [Abstract][Full Text] [Related]
13. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis between follicular adenoma and follicular carcinoma of the thyroid by nuclear DNA determination.
Sprenger E; Löwhagen T; Vogt-Schaden M
Acta Cytol; 1977; 21(4):528-30. PubMed ID: 269603
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
16. Cytoarchitectural and kinetic features in the histological evaluation of follicular thyroid neoplasms.
Arif S; Patel J; Blanes A; Diaz-Cano SJ
Histopathology; 2007 May; 50(6):750-63. PubMed ID: 17493239
[TBL] [Abstract][Full Text] [Related]
17. Follicular lesions of the thyroid: intraoperative cytology.
Costa MJ; Sidawy MK
Mod Pathol; 1989 Sep; 2(5):521-5. PubMed ID: 2813348
[TBL] [Abstract][Full Text] [Related]
18. Morphometric parameters and silver stain used in diagnosis of thyroid follicular diseases.
Ciobanu D; Căruntu ID; Vulpoi C; Florea N; Giuşcă SE
Rom J Morphol Embryol; 2006; 47(4):323-30. PubMed ID: 17392977
[TBL] [Abstract][Full Text] [Related]
19. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
20. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases].
Yang QX; Shao CK; Feng ZY; Huang BQ; Han AJ; Xiong M; Zhao WL; Wu TT
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):678-81. PubMed ID: 15958307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
